HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Raymond E Meyn Selected Research
Raymond E Meyn Research Topics
Disease
29
Neoplasms (Cancer)
01/2022 - 03/2002
9
Squamous Cell Carcinoma of Head and Neck
01/2021 - 01/2012
6
Prostatic Neoplasms (Prostate Cancer)
07/2014 - 03/2002
6
Melanoma (Melanoma, Malignant)
08/2006 - 06/2004
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 11/2003
3
Head and Neck Neoplasms (Head and Neck Cancer)
01/2021 - 02/2015
3
Lung Neoplasms (Lung Cancer)
08/2014 - 07/2002
2
Neoplasm Metastasis (Metastasis)
08/2014 - 02/2006
2
Breast Neoplasms (Breast Cancer)
07/2014 - 12/2007
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2008 - 04/2004
1
Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2018
1
Hematologic Neoplasms (Hematological Malignancy)
03/2017
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2017
1
Rectal Neoplasms (Rectal Cancer)
04/2016
1
Hypoxia (Hypoxemia)
12/2015
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2009
1
Disease Progression
09/2009
1
Ataxia Telangiectasia (Louis Bar Syndrome)
11/2003
1
B-Cell Lymphoma (Lymphoma, B Cell)
08/2003
Drug/Important Bio-Agent (IBA)
3
Proteins (Proteins, Gene)
FDA Link
01/2018 - 07/2005
3
Biomarkers (Surrogate Marker)
IBA
03/2017 - 12/2015
3
Cytokines
IBA
12/2007 - 08/2003
3
Histone Deacetylase Inhibitors
IBA
11/2006 - 07/2005
3
interleukin-24 (ST16)
IBA
02/2006 - 08/2003
2
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 02/2004
2
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2021 - 07/2014
2
niraparib
IBA
01/2021 - 07/2014
2
Cisplatin (Platino)
FDA Link
Generic
03/2017 - 02/2015
2
Lactic Acid (Lactate)
FDA Link
Generic
03/2017 - 12/2015
2
Messenger RNA (mRNA)
IBA
09/2016 - 07/2005
2
Phosphotransferases (Kinase)
IBA
02/2015 - 09/2011
2
adavosertib
IBA
02/2015 - 09/2011
2
ErbB Receptors (EGF Receptor)
IBA
01/2015 - 02/2008
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2007 - 06/2004
2
trichostatin A (A 300)
IBA
11/2006 - 07/2005
2
Radiation-Sensitizing Agents
IBA
07/2005 - 08/2004
2
DNA-Activated Protein Kinase
IBA
07/2005 - 11/2003
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
08/2004 - 08/2003
2
NF-kappa B (NF-kB)
IBA
08/2004 - 08/2003
1
Ubiquitin
IBA
01/2022
1
Small Interfering RNA (siRNA)
IBA
01/2021
1
Deubiquitinating Enzymes
IBA
01/2018
1
Doxorubicin (Adriamycin)
FDA Link
Generic
03/2017
1
Platinum
IBA
03/2017
1
Carboplatin (JM8)
FDA Link
Generic
03/2017
1
MK-8776
IBA
11/2016
1
1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)
IBA
11/2016
1
Checkpoint Kinase 1
IBA
11/2016
1
Nelfinavir (Viracept)
FDA Link
04/2016
1
HIV Protease Inhibitors
IBA
04/2016
1
Free Radical Scavengers
IBA
12/2015
1
Cetuximab (Erbitux)
FDA Link
01/2015
1
cixutumumab
IBA
01/2015
1
Somatomedin Receptors (Somatomedin Receptor)
IBA
01/2015
1
MicroRNAs (MicroRNA)
IBA
08/2014
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
07/2014
1
Metformin (Glucophage)
FDA Link
Generic
01/2012
1
ABT-737
IBA
12/2009
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
09/2009
1
Gefitinib (Iressa)
FDA Link
02/2008
1
Luciferases
IBA
12/2007
1
Becaplermin (PDGF-BB)
FDA Link
12/2007
1
Chemokine Receptors
IBA
12/2007
1
Firefly Luciferases
IBA
12/2007
1
Transforming Growth Factor beta1 (TGF beta 1)
IBA
12/2007
1
Renilla Luciferases
IBA
12/2007
1
Inhibitor of Apoptosis Proteins
IBA
11/2006
1
Survivin
IBA
11/2006
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
11/2006
1
Mitogen-Activated Protein Kinases
IBA
11/2006
1
6- ((3- chloro)anilino)- 2- (isopropyl- 2- hydroxyethylamino)- 9- isopropylpurine
IBA
11/2006
1
2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- one
IBA
11/2006
1
Vorinostat
FDA Link
08/2006
1
Histone Deacetylases (Histone Deacetylase)
IBA
08/2006
1
Chromatin
IBA
08/2006
1
Antigens
IBA
02/2006
1
Granzymes (Granzyme)
IBA
02/2006
1
Butyric Acid (Butanoic Acid)
IBA
07/2005
1
Histones (Histone)
IBA
07/2005
1
tributyrin
IBA
07/2005
1
benzyloxycarbonylleucyl-leucyl-leucine aldehyde
IBA
08/2004
1
2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamide
IBA
08/2004
1
bcl-2-Associated X Protein (bcl 2 Associated X Protein)
IBA
04/2004
1
Complementary DNA (cDNA)
IBA
03/2004
1
advexin
IBA
11/2003
1
Cadherins (E-Cadherin)
IBA
08/2003
1
beta Catenin
IBA
08/2003
1
harringtonin
IBA
06/2003
1
Puromycin
IBA
06/2003
1
Emetine
IBA
06/2003
1
Cycloheximide (Cicloheximide)
IBA
06/2003
1
Anisomycin
IBA
06/2003
1
JNK Mitogen-Activated Protein Kinases
IBA
06/2003
1
Ligands
IBA
06/2003
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
06/2003
1
Therapeutic Uses
IBA
07/2002
Therapy/Procedure
17
Radiotherapy
01/2022 - 04/2004
6
Therapeutics
01/2022 - 06/2004
4
Drug Therapy (Chemotherapy)
03/2017 - 02/2006
1
Aftercare (After-Treatment)
09/2016